Evidence map›Paper›PMID 38206818›Full record

ArticleThe oncologist2024

Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.

Anthony V Serritella, Himisha Beltran, Tamara L Lotan, David J VanderWeele, Fatima Karzai, Ravi A Madan, Maha Hussain

Open access · goldAbstract read
In one paragraph

Article in The oncologist, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. RUNX1T1 drives stem-like small-cell neuroendocrine prostate cancer identity.Frontiers in cell and developmental biology · 2026
    Article
  3. Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Anthony V SerritellaRobert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0009-0006-9887-3054
Himisha BeltranDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-3259-2226
Tamara L LotanDepartment of Pathology, Department of Urology, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
David J VanderWeeleRobert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Fatima KarzaiGenitourinary Malignancies Branch Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ravi A MadanGenitourinary Malignancies Branch Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-5106-8636
Maha HussainRobert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0003-0380-9465
Northwestern University · USNational Institutes of Health · USHarvard University · USJohns Hopkins University · US

Funding

Molecular mechanisms underlying lineage plasticity in prostate cancerR37CA241486 · NCI · DANA-FARBER CANCER INST · PI Himisha Beltran · 2020 to 2026
$4.1M
Evaluation of Immune-based Combinations in Prostate CancerZIABC011897 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MADAN, RAVI · 2019 to 2025
$3.1M
NCI NIH HHS R37 CA241486
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, NeuroendocrineProstatic NeoplasmsHumansMale

Identifiers

PMID38206818
PMCPMC10911908
OpenAlexW4390754528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.